Immunome, Inc. · NASDAQ:IMNM
Lechleider Robert received 54,000 Immunome, Inc. shares as an award (Form 4)
Traded Jul 23, 2026 · Filed Jul 27, 2026
On Jul 23, 2026, Lechleider Robert (Chief Medical Officer) received 54,000 Immunome, Inc. shares as an award, leaving 69,805 shares. Filed Jul 27, 2026 (Form 4).
- Awarded
- 54,000 shares
- Holding after
- 69,805 shares
- Trading plan
- No
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 23, 2026 | Common Stock | Award | 54,000 | 69,805 | Direct |
Source
Related
- Immunome, Inc.
- Lechleider Robert
- Immunome, Inc. shareholders
- Form 4 · Lechleider Robert · Jul 7, 2026
- Form 4 · Lechleider Robert · Jun 29, 2026
- Form 4 · Higgins Jack · Sep 15, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Aug 14, 2026
- Form 4 · Barchas Isaac · Aug 12, 2026
- Form 4 · Barchas Isaac · Aug 10, 2026